XML 30 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Certain Financial Statement Information
6 Months Ended
Sep. 30, 2014
Certain Financial Statement Information [Abstract]  
CERTAIN FINANCIAL STATEMENT INFORMATION
CERTAIN FINANCIAL STATEMENT INFORMATION
Accounts receivable:
 
 
September 30,
2014
 
March 31,
2014
 
 
(In thousands)
Accounts receivable
 
$
18,275

 
$
25,629

Less: allowance for bad debts
 
(394
)
 
(451
)
 
 
$
17,881

 
$
25,178



Inventories:
 
 
September 30,
2014
 
March 31,
2014
 
 
(In thousands)
Finished goods
 
$
10,713

 
$
9,375

Work in process
 
5,457

 
6,510

Raw materials
 
1,422

 
3,061

 
 
$
17,592

 
$
18,946



Other current assets:
 
 
September 30,
2014
 
March 31,
2014
 
 
(In thousands)
Prepaid expenses
 
$
11,305

 
$
10,978

Executive deferred compensation assets
 
1,058

 
1,035

Deposits
 
543

 
585

Proceeds receivable from sale of strategic investment
 

 
3,353

Other
 
764

 
848

 
 
$
13,670

 
$
16,799



Property and equipment:
 
 
Useful
Life
 
September 30,
2014
 
March 31,
2014
 
 
(In years)
 
(In thousands)
Machinery and equipment
 
3-5
 
$
46,032

 
$
44,503

Leasehold improvements
 
1-5
 
12,911

 
11,574

Computers, office furniture and equipment
 
3-5
 
44,970

 
43,365

 
 
 
 
103,913

 
99,442

Less: accumulated depreciation and amortization
 
 
 
(83,130
)
 
(78,696
)
 
 
 
 
$
20,783

 
$
20,746



Goodwill and purchased intangibles:
Goodwill is as follows:
 
September 30,
2014
 
March 31,
2014
 
(In thousands)
Goodwill
$
11,425

 
$
11,425




Purchase-related intangibles are as follows:
 
 
September 30, 2014
 
March 31, 2014
 
 
Gross
 
Accumulated
Amortization
and Impairments
 
Net
 
Weighted
average
remaining
useful life
 
Gross
 
Accumulated
Amortization
and Impairments
 
Net
 
Weighted
average
remaining
useful life
 
 
(In thousands)
 
(In years)
 
(In thousands)
 
(In years)
Developed technology/in-process research and development
 
$
425,000

 
$
(425,000
)
 
$

 
0.0
 
$
425,000

 
$
(425,000
)
 
$

 
0.0
Customer relationships
 
6,330

 
(6,330
)
 

 
0.0
 
6,330

 
(6,225
)
 
105

 
0.4
Patents/core technology rights/trade name
 
62,306

 
(62,306
)
 

 
0.0
 
62,306

 
(62,306
)
 

 
0.0
 
 
$
493,636

 
$
(493,636
)
 
$

 
 
 
$
493,636

 
$
(493,531
)
 
$
105

 
 

 
Other assets:
 
 
September 30,
2014
 
March 31,
2014
 
 
(In thousands)
Non-current portion of prepaid expenses
 
$
3,258

 
$
4,235

Strategic investments*
 
500

 
3,000

Other
 
520

 
519

 
 
$
4,278

 
$
7,754


*Strategic investments
The Company has entered into certain equity investments in privately held businesses to achieve certain strategic business objectives. The Company’s investments in equity securities of privately held businesses are accounted for under the cost method. Under the cost method, strategic investments in which the Company holds less than a 20% voting interest and in which the Company does not have the ability to exercise significant influence are carried at cost reduced by other-than-temporary impairments, as appropriate. The Company periodically reviews these investments for other-than-temporary declines in fair value based on the specific identification method and writes down investments when an other-than-temporary decline has occurred. During the three and six months ended September 30, 2014, the Company recorded an other-than-temporary impairment charge with respect to one of its strategic investments in the amount of $2.5 million. During the three and six months ended September 30, 2013, the Company did not record any other-than-temporary impairment charges with respect to its strategic investments.

Other accrued liabilities:
 
 
September 30,
2014
 
March 31,
2014
 
 
(In thousands)
Employee related liabilities
 
$
1,681

 
$
1,733

Executive deferred compensation
 
1,339

 
1,314

Income taxes
 
1,075

 
962

Professional fees
 
1,054

 
1,259

Other
 
2,672

 
5,609

 
 
$
7,821

 
$
10,877


Short-term investments:
The following is a summary of cash, cash equivalents and available-for-sale investments by type of instrument (in thousands):
 
 
September 30, 2014
 
March 31, 2014
 
 
Amortized
Cost
 
Gross Unrealized
 
Estimated
Fair Value
 
Amortized
Cost
 
Gross Unrealized
 
Estimated
Fair Value
 
 
Gains
 
Losses
 
Gains
 
Losses
 
Cash
 
$
47,709

 
$

 
$

 
$
47,709

 
$
65,867

 
$

 
$

 
$
65,867

Cash equivalents
 
6,237

 

 

 
6,237

 
5,672

 

 

 
5,672

U.S. Treasury securities and agency bonds
 
2,842

 

 

 
2,842

 
2,838

 

 

 
2,838

Corporate bonds
 
10,881

 
24

 
(4
)
 
10,901

 
10,599

 
30

 
(2
)
 
10,627

Mortgage-backed and asset-backed securities*
 
1,654

 
309

 
(3
)
 
1,960

 
1,793

 
297

 
(16
)
 
2,074

Closed-end bond funds
 
14,373

 
2,437

 
(128
)
 
16,682

 
14,373

 
2,392

 
(402
)
 
16,363

Preferred stock
 
2,406

 
781

 

 
3,187

 
2,406

 
736

 

 
3,142

 
 
$
86,102

 
$
3,551

 
$
(135
)
 
$
89,518

 
$
103,548

 
$
3,455

 
$
(420
)
 
$
106,583

Reported as:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
 
 
 
 
 
 
$
53,946

 
 
 
 
 
 
 
$
71,539

Short-term investments available-for-sale
 
 
 
 
 
 
 
35,572

 
 
 
 
 
 
 
35,044

 
 
 
 
 
 
 
 
$
89,518

 
 
 
 
 
 
 
$
106,583

 

* At September 30, 2014 and March 31, 2014, approximately $1.0 million and $1.1 million of the estimated fair value presented were mortgage-backed securities, respectively.
The established guidelines for measuring fair value and expanded disclosures regarding fair value measurements are defined as a three-level valuation hierarchy for disclosure of fair value measurements as follows:
Level 1 — Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
Level 2 — Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.
Level 3 — Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities.
The following is a summary of cash, cash equivalents and available-for-sale investments by type of instrument measured at fair value on a recurring basis (in thousands):
 
 
September 30, 2014
 
March 31, 2014
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash
 
$
47,709

 
$

 
$

 
$
47,709

 
$
65,867

 
$

 
$

 
$
65,867

Cash equivalents
 
6,237

 

 

 
6,237

 
5,672

 

 

 
5,672

U.S. Treasury securities and agency bonds
 
2,842

 

 

 
2,842

 
2,838

 

 

 
2,838

Corporate bonds
 

 
10,901

 

 
10,901

 

 
10,627

 

 
10,627

Mortgage-backed and asset-backed securities
 

 
1,960

 

 
1,960

 

 
2,074

 

 
2,074

Closed-end bond funds
 
16,682

 

 

 
16,682

 
16,363

 

 

 
16,363

Preferred stock
 

 
3,187

 

 
3,187

 

 
3,142

 

 
3,142

 
 
$
73,470

 
$
16,048

 
$

 
$
89,518

 
$
90,740

 
$
15,843

 
$

 
$
106,583


There were no significant transfers in and out of Level 1 and Level 2 fair value measurement categories during the three and six months ended September 30, 2014 and 2013.
The following is a summary of the cost and estimated fair values of available-for-sale securities with stated maturities, which include U.S. Treasury securities and agency bonds, corporate bonds and mortgage-backed and asset-backed securities, by contractual maturity (in thousands):
 
 
September 30, 2014
 
 
Cost
 
Estimated Fair Value
Less than 1 year
 
$
7,663

 
$
7,762

Mature in 1 – 2 years
 
6,182

 
6,221

Mature in 3 – 5 years
 
704

 
714

Mature after 5 years
 
828

 
1,006

 
 
$
15,377

 
$
15,703


The following is a summary of gross unrealized losses (in thousands):
 
 
Less Than 12 Months of
Unrealized Losses
 
12 Months or More of
Unrealized Losses
 
Total
As of September 30, 2014
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
Corporate bonds
 
$
3,132

 
$
(4
)
 
$

 
$

 
$
3,132

 
$
(4
)
Mortgage-backed and asset-backed securities
 
173

 

 
116

 
(2
)
 
289

 
(2
)
Closed-end bond funds
 
42

 
(1
)
 
5,450

 
(128
)
 
5,492

 
(129
)
 
 
$
3,347

 
$
(5
)
 
$
5,566

 
$
(130
)
 
$
8,913

 
$
(135
)
 
 
Less Than 12 Months of
Unrealized Losses
 
12 Months or More of
Unrealized Losses
 
Total
As of March 31, 2014
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
 
Estimated
Fair
Value
 
Gross
Unrealized
Losses
Corporate bonds
 
$
992

 
$
(2
)
 
$

 
$

 
$
992

 
$
(2
)
Mortgage-backed and asset-backed securities
 
431

 
(16
)
 

 

 
431

 
(16
)
Closed-end bond funds
 
4,819

 
(333
)
 
405

 
(69
)
 
5,224

 
(402
)
 
 
$
6,242

 
$
(351
)
 
$
405

 
$
(69
)
 
$
6,647

 
$
(420
)

Other-Than-Temporary Impairment
Based on an evaluation of securities that have been in a loss position, the Company did not recognize any other-than-temporary impairment charges for the three and six months ended September 30, 2014 and 2013. The Company considered various factors which included a credit and liquidity assessment of the underlying securities and the Company’s intent and ability to hold the underlying securities until the estimated date of recovery of its amortized cost. As of September 30, 2014 and March 31, 2014, the Company also had $3.6 million and $3.5 million in gross unrealized gains, respectively. The basis for computing realized gains or losses is by specific identification.

Warranty reserves:
The Company's products typically carry a one-year warranty. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized. Although the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, use of materials, and service delivery costs incurred in correcting any product failure. Should actual product failure rates, use of materials or service delivery costs differ from the Company’s estimates, additional warranty reserves could be required, which could reduce its gross margin.
The following table summarizes warranty reserve activity (in thousands):

 
Three Months Ended
 
Six Months Ended
 
September 30,
 
September 30,
 
2014
 
2013
 
2014
 
2013
Beginning balance
$
177

 
$
203

 
$
199

 
$
220

Addition to (consumption of) reserve
6

 
(11
)
 
(1
)
 
(26
)
Settlements and expirations
(8
)
 
(5
)
 
(23
)
 
(7
)
Ending balance
$
175

 
$
187

 
$
175

 
$
187



Interest income, net (in thousands):
 
 
Three Months Ended
 
Six Months Ended
 
 
September 30,
 
September 30,
 
 
2014
 
2013
 
2014
 
2013
Interest income
 
$
388

 
$
402

 
$
729

 
$
870

Net realized gain on short-term investments
 
5

 
86

 

 
3,284

 
 
$
393

 
$
488

 
$
729

 
$
4,154



Net loss per share:
Shares used in basic net loss per share are computed using the weighted average number of common shares outstanding during each period. Shares used in diluted net loss per share include the dilutive effect of common shares potentially issuable upon the exercise of stock options and vesting of restricted stock units ("RSUs"). The reconciliation of shares used to calculate basic and diluted net loss per share consists of the following (in thousands, except per share data):

 
 
Three Months Ended
 
Six Months Ended
 
 
September 30,
 
September 30,
 
 
2014
 
2013
 
2014
 
2013
Net loss
 
$
(11,717
)
 
$
(32,383
)
 
$
(24,782
)
 
$
(21,526
)
Shares used in net loss per share computation:
 
 
 
 
 
 
 
 
Weighted average common shares outstanding, basic
 
78,487

 
72,610

 
78,202

 
70,985

Net effect of dilutive common share equivalents
 

 

 

 

Weighted average common shares outstanding, diluted
 
78,487

 
72,610

 
78,202

 
70,985

Basic and diluted net loss per share
 
$
(0.15
)
 
$
(0.45
)
 
$
(0.32
)
 
$
(0.30
)

The effect of dilutive securities (comprised of options and restricted stock units) totaling 1.0 million and 1.2 million shares for the three and six months ended September 30, 2014, respectively, and 1.7 million and 1.3 million shares for the three and six months ended September 30, 2013, respectively, has been excluded from the diluted net loss per share computation since the Company incurred net losses in the periods presented and their effect would be antidilutive.